SCHEMBL32690672

SCHEMBL32690672

O=c1c(O)c(-c2ccccc2C(F)(F)F)[nH]c2cc(Br)ccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGES O14684 1/20 0.44
▸ GSK3B P49841 6/20 0.43
▸ CDK5 Q00535 5/20 0.43
▸ CDK5R1 Q15078 5/20 0.43
▸ CCNB2 O95067 4/20 0.43
▸ CDK1 P06493 4/20 0.43
▸ CCNB1 P14635 4/20 0.43
▸ CCNB3 Q8WWL7 4/20 0.43
▸ GSK3A P49840 3/20 0.41
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690692 0.90 CHEK1 (0.43) PTGESGSK3BCDK5CDK5R1CCNB2
SCHEMBL32690833 0.85 AR (0.51) GSK3BCDK5CDK5R1CCNB2CDK1
SCHEMBL32690843 0.84 MEN1 (0.46) MEN1KMT2ARAB9ANPC1LMNA
SCHEMBL32690754 0.84 FFAR4 (0.48) LMNASMN1; SMN2
SCHEMBL32690859 0.82 MAP4K4 (0.46) MEN1KMT2ARAB9ALMNAMAPT
SCHEMBL32690752 0.81 CTSV (0.46) GSK3BCDK5CDK5R1CCNB2CDK1
SCHEMBL32690840 0.79 HDAC1 (0.42) RAB9ANPC1PKMSMN1; SMN2
SCHEMBL23270975 0.79 TRPA1 (0.44) MEN1KMT2ACYP3A4TDP1GAA
SCHEMBL32690706 0.78 AR (0.51) GSK3BCDK5CDK5R1CCNB2CDK1
Hydrochloric Acid SCHEMBL23271094 0.78 TRPA1 (0.43) MEN1KMT2ACYP3A4TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB PTGES 1068/4885GSK3B 229/4885CDK5 1932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback